Sarepta Therapeutics (BSP:S1RP34) Ending Cash Position : R$1,182 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Sarepta Therapeutics Ending Cash Position?

Sarepta Therapeutics's Ending Cash Position for the quarter that ended in Sep. 2024 was R$1,182 Mil.

Sarepta Therapeutics's quarterly Ending Cash Position declined from Mar. 2024 (R$2,205 Mil) to Jun. 2024 (R$2,150 Mil) and declined from Jun. 2024 (R$2,150 Mil) to Sep. 2024 (R$1,182 Mil).

Sarepta Therapeutics's annual Ending Cash Position declined from Dec. 2021 (R$12,020 Mil) to Dec. 2022 (R$5,171 Mil) and declined from Dec. 2022 (R$5,171 Mil) to Dec. 2023 (R$2,176 Mil).

Sarepta Therapeutics Ending Cash Position Historical Data

The historical data trend for Sarepta Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sarepta Therapeutics Ending Cash Position Chart

Sarepta Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

3,462.74

7,777.31

12,019.62

5,170.92

2,175.56

Sarepta Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial															2,771.01	2,175.56	2,205.40	2,150.14	1,181.96

Sarepta Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sarepta Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4830.228	+	-2654.673
	=	2,176

Sarepta Therapeutics's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2210.695	+	-1028.74
	=	1,182

Sarepta Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Sarepta Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Sarepta Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sarepta Therapeutics Inc (BSP:S1RP34) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

SRPT:USA 0L35:UK AB3A:Germany AB3A:Germany

Address

215 First Street, Suite 415, Cambridge, MA, USA, 02142

Website

https://www.sarepta.com

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.

Sarepta Therapeutics Headlines

No Headlines